Free research / Peptide starting point
SS-31 research
Browse source-linked original-study metadata associated with SS-31. Records are selected by a bounded search and automated metadata rules; they are not reviewed Pependium judgments about safety or effectiveness. Check each original source for its full methods and current status.
Elamipretide (SS-31) and Nicotinamide Mononucleotide (NMN) Combination Therapy Targets TREM2 to Mitigate Post-ischemic Brain Injury in Mice.
SS31 protects damaged retinal cells through the AMPK/DRP1 signaling pathway.
Mitochondrial-targeted SS-31 peptide attenuates radiation-induced cardiomyocyte senescence.
Mitochondrial-Targeted SS-31 Attenuates the Doxorubicin-Induced Cardiomyoblast H9C2 Cell Senescence.
Targeting Mitochondrial Dysfunction With Elamipretide (SS-31) Improves Skeletal Muscle Performance in a HFpEF Rat Model.
Elamipretide (SS-31) promotes recovery by preserving mitochondrial bioenergetics and neural remodeling after spinal cord injury.
Dual action of SS31 via NRF2/HO-1: countering oxidative stress and metabolic dysfunction in ovarian aging.
Check collection progress and source responses · All peptide pages